Israel
· Delayed Price · Currency is ILS · Price in ILAOPKO Health Statistics
Total Valuation
OPKO Health has a market cap or net worth of ILS 4.03 billion. The enterprise value is 4.88 billion.
| Market Cap | 4.03B |
| Enterprise Value | 4.88B |
Important Dates
The next estimated earnings date is Thursday, November 7, 2024.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
| Shares Outstanding | n/a |
| Shares Change (YoY) | -3.27% |
| Shares Change (QoQ) | -1.37% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 281.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.54 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.33 |
| EV / Sales | 1.84 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -15.06 |
Financial Position
The company has a current ratio of 1.63, with a Debt / Equity ratio of 19.31.
| Current Ratio | 1.63 |
| Quick Ratio | 0.71 |
| Debt / Equity | 19.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.13 |
| Interest Coverage | -11.79 |
Financial Efficiency
Return on equity (ROE) is -16.59% and return on invested capital (ROIC) is -9.57%.
| Return on Equity (ROE) | -16.59% |
| Return on Assets (ROA) | -8.09% |
| Return on Capital (ROIC) | -9.57% |
| Revenue Per Employee | 686,314 |
| Profits Per Employee | -232,897 |
| Employee Count | 3,930 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 9.26 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.74% in the last 52 weeks. The beta is 1.64, so OPKO Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.64 |
| 52-Week Price Change | -13.74% |
| 50-Day Moving Average | 548.11 |
| 200-Day Moving Average | 477.19 |
| Relative Strength Index (RSI) | 47.73 |
| Average Volume (20 Days) | 257,069 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 30.77 |
Income Statement
In the last 12 months, OPKO Health had revenue of ILS 2.70 billion and -915.28 million in losses. Loss per share was -1.26.
| Revenue | 2.70B |
| Gross Profit | 363.38M |
| Operating Income | -1.01B |
| Pretax Income | -921.21M |
| Net Income | -915.28M |
| EBITDA | -622.95M |
| EBIT | -1.01B |
| Loss Per Share | -1.26 |
Balance Sheet
The company has 152.77 million in cash and 1.01 billion in debt, giving a net cash position of -861.73 million.
| Cash & Cash Equivalents | 152.77M |
| Total Debt | 1.01B |
| Net Cash | -861.73M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 5.25B |
| Book Value Per Share | 7.53 |
| Working Capital | 521.20M |
Cash Flow
In the last 12 months, operating cash flow was -252.96 million and capital expenditures -71.10 million, giving a free cash flow of -324.07 million.
| Operating Cash Flow | -252.96M |
| Capital Expenditures | -71.10M |
| Free Cash Flow | -324.07M |
| FCF Per Share | n/a |
Margins
Gross margin is 13.47%, with operating and profit margins of -37.37% and -33.93%.
| Gross Margin | 13.47% |
| Operating Margin | -37.37% |
| Pretax Margin | -34.15% |
| Profit Margin | -33.93% |
| EBITDA Margin | -23.10% |
| EBIT Margin | -37.37% |
| FCF Margin | -12.01% |
Dividends & Yields
OPKO Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.27% |
| Shareholder Yield | 3.27% |
| Earnings Yield | -22.08% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |